ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 5 January to 11 January 2026

The 10 most important of the 128 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Cardiology · Heart Rhythm · 2026-01-07

Meta-analysis of 32 studies (271,808 patients) after AF ablation: stopping oral anticoagulants was not associated with thromboembolism (OR 0.90, 0.68–1.20) or mortality, but with less major bleeding (OR 0.35); with CHA2DS2-VASc >2, stopping raised thromboembolic risk.

Meta-analysisn = 271,808
Barbosa et al. Can oral anticoagulants be safely discontinued after atrial fibrillation ablation? A systematic review and meta-analysis of reconstructed time-to-event data
Critical care and emergency · Crit Care Med · 2026-01-08

Systematic review of 18 studies (20,617 patients) of microaxial flow pump support for AMI-related cardiogenic shock: median short-term mortality 50.7%; older age, female sex, cardiac arrest, mechanical ventilation and hypoxic-ischaemic brain injury were linked to death.

Meta-analysisn = 20,617
Parlow et al. Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
Urology · World J Urol · 2026-01-06

Network meta-analysis of 40 publications (12 201 men with LUTS/BPH): doxazosin GITS 4mg gave the largest IPSS improvement (-10.07) and was superior to most tamsulosin doses, with similar overall tolerability; voiding scores and flow did not differ.

Meta-analysisn = 12,201
Oelke et al. Doxazosin versus tamsulosin for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic literature review and network meta-analysis
Oncology · Cancer Treat Rev · 2026-01-06

Meta-analysis of 13 retrospective studies (7206 patients) of early HER2-positive breast cancer given anti-HER2 neoadjuvant therapy: pCR was higher in IHC 3+ than 2+/ISH+ tumours (55.1% vs 21.6%; OR 5.38); 3-year invasive DFS did not differ significantly.

Meta-analysisn = 7,206
Yucel et al. Comparison of the pathological complete response between immunohistochemistry HER2 (3 + ) and HER2 (2 + )/ISH + Early-stage breast cancer: a systematic review and meta-analysis
Anaesthesia and pain · Anaesthesia · 2026-01-08

Rapid systematic review of 21 RCTs in critically ill adults with sepsis: procalcitonin-guided antibiotic stopping probably shortened therapy by 2.0 days vs standard care (19 trials), with no clear mortality difference (RR 0.95, 0.83–1.07). CRP-guided evidence was low certainty.

Meta-analysisn = 6,382
Rafiq et al. Clinical effectiveness of procalcitonin- or C-reactive protein-guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.